Skip to main content
. 2015 Jan 31;35(3):211–219. doi: 10.1007/s40261-014-0266-2
The efficacy of dolutegravir has been demonstrated in randomized studies in integrase inhibitor-naive adult populations.
To date, a detailed review of the dolutegravir lipid profile has not been provided in the literature.
Dolutegravir has shown a broadly neutral effect on serum lipids in comparative clinical trials.